Alpine Global Management, LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Alpine Global Management, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2021$614,000
+17.6%
15,880
-46.7%
0.09%
-15.1%
Q4 2020$522,000–29,820–0.11%–
 Download
Other shareholders

There were no reported owners of CELLDEX THERAPEUTICS INC NEW in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders